journal article·2024-10Open access

MAPK Signaling‐Mediated RFNG Phosphorylation and Nuclear Translocation Restrain Oxaliplatin‐Induced Apoptosis and Ferroptosis

Yuqin Di, Xiang Zhang, Xiangqiong Wen, Jiale Qin, Lvlan Ye, Youpeng Wang, Mei Song, Ziyang Wang, Weiling He

Advanced Science· Volume 11· Issue 38

Abstract

Abstract Chemotherapy resistance remains a major challenge in the treatment of colorectal cancer (CRC). Therefore, it is crucial to develop novel strategies to sensitize cancer cells to chemotherapy. Here, the fringe family is screened to determine their contribution to chemotherapy resistance in CRC. It is found that RFNG depletion significantly sensitizes cancer cells to oxaliplatin treatment. Mechanistically, chemotherapy‐activated MAPK signaling induces ERK to phosphorylate RFNG Ser255 residue. Phosphorylated RFNG S255 (pS255) interacts with the nuclear importin proteins KPNA1/importin‐α1 and KPNB1/importin‐β1, leading to its translocation into the nucleus where it targets p53 and inhibits its phosphorylation by competitively inhibiting the binding of CHK2 to p53. Consequently, the expression of CDKN1A is decreased and that of SLC7A11 is increased, leading to the inhibition of apoptosis and ferroptosis. In contrast, phosphor‐deficient RFNG S225A mutant showed increased apoptosis and ferroptosis, and exhibited a notable response to oxaliplatin chemotherapy both in vitro and in vivo. It is further revealed that patients with low RFNG pS255 exhibited significant sensitivity to oxaliplatin in a patient‐derived xenograft (PDX) model. These findings highlight the crosstalk between the MAPK and p53 signaling pathways through RFNG, which mediates oxaliplatin resistance in CRC. Additionally, this study provides guidance for oxaliplatin treatment of CRC patients.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer, Lipids, and Metabolism · Ferroptosis and cancer prognosis · Cancer-related Molecular Pathways

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Molecular Diagnosis and Gene Testing Center The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510080 China

Department of Gastrointestinal Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510080 China

Department of Biochemistry Zhongshan School of Medicine Sun Yat‐sen University Guangzhou Guangdong 510080 China

Center of Hepato‐Pancreato‐Biliary Surgery The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510080 China

Institute of Precision Medicine The First Affiliated Hospital Sun Yat‐Sen University Guangzhou Guangdong 510080 China

Center for Translational Medicine The First Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510080 China

Department of Gastrointestinal Surgery Xiang'an Hospital of Xiamen University School of Medicine Xiamen University Xiamen Fujian 361000 China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation

References (45)

Show source-provided references
1. 10.1056/NEJMc220665210.1056/NEJMc2206652 ↗
2. 10.1001/jamaoncol.2019.648610.1001/jamaoncol.2019.6486 ↗
3. 10.1200/JCO.2000.18.16.293810.1200/JCO.2000.18.16.2938 ↗
4. 10.1016/j.drup.2011.08.00110.1016/j.drup.2011.08.001 ↗
5. 10.1038/s41568-020-0262-110.1038/s41568-020-0262-1 ↗
6. 10.1016/j.tcb.2020.12.01110.1016/j.tcb.2020.12.011 ↗
7. 10.1158/0008-5472.CAN-06-428210.1158/0008-5472.CAN-06-4282 ↗
8. 10.1038/nature1434410.1038/nature14344 ↗
9. 10.7554/eLife.4184410.7554/eLife.41844 ↗
10. 10.1016/j.jbc.2022.10206410.1016/j.jbc.2022.102064 ↗
11. 10.1016/j.ccr.2012.03.04110.1016/j.ccr.2012.03.041 ↗
12. 10.1158/0008-5472.CAN-14-330310.1158/0008-5472.CAN-14-3303 ↗
13. Reedijk M. · Int. J. Oncol. · 2008 · 33 · 1223
14. 10.1007/s10585-010-9305-410.1007/s10585-010-9305-4 ↗
15. 10.1371/journal.pmed.100145310.1371/journal.pmed.1001453 ↗
16. 10.1371/journal.pone.010674810.1371/journal.pone.0106748 ↗
17. 10.1038/s41467-022-29309-110.1038/s41467-022-29309-1 ↗
18. 10.1158/0008-5472.CAN-19-257810.1158/0008-5472.CAN-19-2578 ↗
19. 10.1038/s41392-023-01347-110.1038/s41392-023-01347-1 ↗
20. 10.1038/s41418-022-00943-y10.1038/s41418-022-00943-y ↗
21. 10.1016/j.drup.2003.10.00410.1016/j.drup.2003.10.004 ↗
22. 10.3390/ijms2108277310.3390/ijms21082773 ↗
23. 10.1053/j.gastro.2011.04.05510.1053/j.gastro.2011.04.055 ↗
24. 10.1016/j.canlet.2014.02.01610.1016/j.canlet.2014.02.016 ↗
25. 10.1038/nrclinonc.2017.15110.1038/nrclinonc.2017.151 ↗
26. 10.1186/s13045-022-01360-x10.1186/s13045-022-01360-x ↗
27. 10.1038/nrc216710.1038/nrc2167 ↗
28. 10.1016/j.trecan.2020.02.02010.1016/j.trecan.2020.02.020 ↗
29. 10.1007/s13105-019-00703-610.1007/s13105-019-00703-6 ↗
30. 10.1016/j.ccell.2018.07.00910.1016/j.ccell.2018.07.009 ↗
31. 10.3390/molecules2619594210.3390/molecules26195942 ↗
32. 10.1038/7430710.1038/74307 ↗
33. 10.1038/2862510.1038/28625 ↗
34. 10.1242/dev.0160110.1242/dev.01601 ↗
35. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
36. 10.1158/0008-5472.CAN-18-303710.1158/0008-5472.CAN-18-3037 ↗
37. 10.1038/s41556-018-0178-010.1038/s41556-018-0178-0 ↗
38. 10.1016/j.ccell.2020.03.01310.1016/j.ccell.2020.03.013 ↗
39. 10.1038/s41573-022-00571-810.1038/s41573-022-00571-8 ↗
40. 10.1016/j.bbrc.2020.09.08510.1016/j.bbrc.2020.09.085 ↗
41. 10.1016/j.drup.2022.10090910.1016/j.drup.2022.100909 ↗
42. 10.1016/j.celrep.2019.01.03010.1016/j.celrep.2019.01.030 ↗
43. 10.1053/j.gastro.2011.07.05010.1053/j.gastro.2011.07.050 ↗
44. 10.1002/advs.20200059310.1002/advs.202000593 ↗
45. 10.1016/j.canlet.2024.21664410.1016/j.canlet.2024.216644 ↗